Roche Holding Target Price $50

Roche Holding Target Price $50

Roche Holding said that the European Commission has approved its influenza treatment Xofluza. The company said Xoflusa was also approved as a post-exposure prophylaxis, meaning as a preventative treatment for individuals who have come in contact with someone infected with an influenza virus. The Commission’s approval–which comes in the wake of a November positive opinion […]